POTENTIAL DECISION DRIVERS FOR POSITIVE RECOMMENDATIONS OF NEW CANCER THERAPIES IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM: ANALYSIS OF RECENT HTA SUBMISSIONS

被引：0
|
作者：
Ribeiro, R. Antonini [1 ]
Marcolino, M. [2 ]
机构：
[1] HTAnalyze Consulting & Training, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande Do Sul UFRGS, Porto Alegre, RS, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA60
引用
收藏
页码：S269 / S270
页数：2
相关论文
共 23 条
  • [1] SUMMARY OF RECENT HEALTH TECHNOLOGY ASSESSMENTS FOR NEW CANCER PHARMACOLOGICAL TECHNOLOGIES IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Marcolino, M.
    Ribeiro, R. Antonini
    VALUE IN HEALTH, 2023, 26 (06) : S266 - S266
  • [2] MULTICRITERIA DECISION ANALYSIS (MCDA) TO ELICIT CRITERIA FOR CAR-T CELL HEALTH TECHNOLOGY ASSESSMENT (HTA) IN BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Amaral, L. Murta
    Bana, J.
    Nakada, C.
    Bezerra, J.
    Fonseca, A. R.
    Dos Reis Neto, J.
    Silveira, T.
    VALUE IN HEALTH, 2023, 26 (12) : S379 - S379
  • [3] A MULTICRITERIA DECISION ANALYSIS (MCDA) TO EVALUATE ALTERNATIVE TREATMENTS FOR LOCALLY ADVANCED OR METASTATIC EGFR POSITIVE NON-SMALL CELL LUNG CANCER UNDER THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE
    Teich, V
    Custodio, M. G.
    Laloni, M. T.
    Costa, M. A. D. S. B.
    Campolina, A. G.
    Holtz, L.
    Oliveira, M.
    Bortoleto, N.
    Salgado, J.
    VALUE IN HEALTH, 2019, 22 : S98 - S98
  • [4] A MULTICRITERIA DECISION ANALYSIS (MCDA) TO EVALUATE ALTERNATIVE TREATMENTS FOR SEVERE ASTHMA IN ADULT PATIENTS UNDER THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE
    Teich, V
    Penha, M. F.
    Sano, F.
    San Martin, G.
    Farina, T.
    Gondo, C.
    Campolina, A. G.
    Mattar, Z. D. L.
    Salgado, J.
    VALUE IN HEALTH, 2019, 22 : S358 - S358
  • [5] NEW CORONARY PROCEDURES AFTER CORONARY INTERVENTION (PCI ABD CABG) IN BRAZILIAN PRIVATE HEALTHCARE SYSTEM: A RWD SECONDARY ANALYSIS
    Fujii, F. A.
    Pianucci, R. D.
    Hume, M.
    Gryzbowski, E.
    Arcos, J.
    Valencia, J.
    VALUE IN HEALTH, 2018, 21 : S57 - S57
  • [6] BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MIDOSTAURIN FOR FLT3-POSITIVE ACUTE MYELOID LEUKEMIA (AML) IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM (BPHS).
    Buehler, A.
    Kim, H. S. J.
    Fahham, L.
    Matsuo, A. L.
    VALUE IN HEALTH, 2019, 22 : S470 - S470
  • [7] BUDGET IMPACT MODEL OF SUBCUTANEOUS TRASTUZUMAB COMPARED WITH INTRAVENOUS TRASTUZUMAB ON THE TREATMENT OF HER-2 POSITIVE BREAST CANCER IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Kashiura, D.
    Souza, P., V
    Garrido, S. D.
    Nardi, E.
    Alves, M.
    VALUE IN HEALTH, 2018, 21 : S26 - S27
  • [8] A MULTICRITERIA DECISION ANALYSIS (MCDA) TO EVALUATE ALTERNATIVE MAINTENANCE STRATEGIES FOR TREATMENT OF RECENTLY DIAGNOSED ADVANCED OVARIAN CANCER (AOC) WITH BRCA MUTATION UNDER THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE
    Teich, V
    Rodrigues, A. N.
    de Freitas, D.
    Gadelha, A. P.
    Oliveira, M.
    Holtz, L.
    Battistini, C. J.
    Santi, A.
    Pombo, F. H.
    Santos, M. C. L.
    Monteiro, I. P.
    Mensor, L.
    VALUE IN HEALTH, 2019, 22 : S506 - S506
  • [9] COST-EFFECTIVENESS ANALYSIS OF ALECTINIB VERSUS CRIZOTINIB IN FIRST LINE ALK-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE
    Stefani, S. D.
    Santos, M.
    Kashiura, D.
    Leme-Souza, R.
    Fahham, L.
    VALUE IN HEALTH, 2019, 22 : S478 - S479
  • [10] PREVENTING BRAIN METASTASES WITH ALECTINIB IN ALK-POSITIVE NON-SMALL CELL LUNG CANCER: ECONOMIC IMPACT UNDER THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE
    Kashiura, D.
    Santos, M.
    Carmo, L.
    Leme-Souza, R.
    VALUE IN HEALTH, 2019, 22 : S80 - S80
123